Y.D. More Investments’s VanEck Pharmaceutical ETF PPH Stock Holding History

Y.D. More Investments’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-120	Closed	-$9.58K	–	361
2023 Q3	$9.58K	Hold	120	–	–	﹤0.01%	312
2023 Q2	$9.45K	Hold	120	–	–	﹤0.01%	289
2023 Q1	$9.32K	Hold	120	–	–	﹤0.01%	302
2022 Q4	$9.37K	Buy	+120	New	+$8.85K	﹤0.01%	351

Other funds holding PPH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Avalon Trust Santa Fe, New Mexico $1.45B AUM 35.31% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northwestern Mutual Wealth Management Milwaukee, Wisconsin $162B AUM 16.35% 1-Year Est. Return

MIM

Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return

PCIA

Prime Capital Investment Advisors Overland Park, Kansas $8.65B AUM 19.52% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Y.D. More Investments's PPH Position: Q4 2023 in Review

Y.D. More Investments sold out of VanEck Pharmaceutical ETF (PPH) in Q4 2023, closing a stake of 120 shares — an estimated $9.58K sold.

Y.D. More Investments first reported a position in PPH in Q4 2022 and held it in 4 quarters. The position peaked at $9.58K in Q3 2023. 110 funds tracked by Wall St. Rank hold PPH as of Q4 2023.

Y.D. More Investments reported no remaining VanEck Pharmaceutical ETF position as of Q4 2023 after selling out during the quarter.
Y.D. More Investments sold 120 VanEck Pharmaceutical ETF shares in Q4 2023, an estimated $9.58K.
Y.D. More Investments first reported a position in VanEck Pharmaceutical ETF in Q4 2022 and held it in 4 quarters.
Y.D. More Investments's VanEck Pharmaceutical ETF position peaked at $9.58K in Q3 2023.
110 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q4 2023.

Based on Y.D. More Investments's 13F filing for Q4 2023, filed 6 Feb 2024.